BPC-157 vs TB-500
BPC-157 is mainly studied for recovery, tissue repair, gut health. while TB-500 is studied for systemic recovery, mobility, tissue flexibility. The difference is in the mechanism and the evidence, not in which is "better": it depends on the goal.
| BPC-157 | TB-500 | |
|---|---|---|
| Category | Regenerative | Regenerative |
| Studied for | Recovery, tissue repair, gut health. | Systemic recovery, mobility, tissue flexibility. |
| How it acts | A peptide associated with tissue-repair signaling; studied for its relationship with angiogenesis and recovery of soft tissue and the digestive tract. | A fragment related to thymosin beta-4, studied for its role in systemic modulation of repair, flexibility and cell migration. |
| Evidence level | Limited human evidence | Human trials available |
How they differ
Although sometimes mentioned together, BPC-157 and TB-500 do not target the same thing. BPC-157: A peptide associated with tissue-repair signaling; studied for its relationship with angiogenesis and recovery of soft tissue and the digestive tract. TB-500: A fragment related to thymosin beta-4, studied for its role in systemic modulation of repair, flexibility and cell migration.
See full entry: BPC-157 → · See full entry: TB-500 →
Want to truly understand it, not memorize it?
The course explains each peptide at a university level: how it acts, what outcomes are studied, what it combines with and when to pause. No doses: the protocol is defined by a professional.
See the course → Start with the free test →Frequently asked questions
What is the main difference between BPC-157 and TB-500?
BPC-157 targets recovery, tissue repair, gut health. and TB-500 targets systemic recovery, mobility, tissue flexibility. They act through different pathways, so the choice depends on your goal, not on which is "stronger".
Can they be studied together?
Combinations are studied by goal in the literature, but combining is not just adding: it changes the safety profile. What to combine and how is decided with a professional; here we only explain what each is studied for.
Which has more human evidence?
Based on the references we verified, TB-500 has more human studies of this pair. Each one's evidence level is in the table above, and the references with their PMID are at the end.
Other comparisons
Was this page useful?
Research moves, and when something relevant changes we update the page. If you want to hear about it for BPC-157 vs TB-500 or any other compound, leave your email. The introductory guide comes with it. No spam, no list-selling; one click to unsubscribe.
References
Every entry links to its record on PubMed, the US National Library of Medicine database. Open them and check. We would rather have a reader who verifies than one who takes our word for it.
- Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Reviewreview HSS J · 2025 · PMID 40756949 →
- Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healingreview Curr Rev Musculoskelet Med · 2025 · PMID 40789979 →
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performancereview Sports Med · 2026 · PMID 41966639 →
- Injectable Therapeutic Peptides-An Adjunct to Regenerative Medicine and Sports Performance?review Arthroscopy · 2025 · PMID 39265666 →
- A first-in-human, randomized, double-blind, single- and multiple-dose, phase I study of recombinant human thymosin β4 in healthy Chinese volunteershuman J Cell Mol Med · 2021 · PMID 34346165 →
- Thymosin β4 significantly improves signs and symptoms of severe dry eye in a phase 2 randomized trialhuman Cornea · 2015 · PMID 25826322 →
- Thymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled, Phase II clinical trial conducted using the controlled adverse environment (CAE) modelhuman Clin Ophthalmol · 2015 · PMID 26056426 →
- A randomized, placebo-controlled, single and multiple dose study of intravenous thymosin beta4 in healthy volunteershuman Ann N Y Acad Sci · 2010 · PMID 20536472 →
Educational content. It does not include doses, protocols or preparation: that is defined by a professional.